Masimo (BSP:M2AS34) Interest Expense: R$-165 Mil (TTM As of Mar. 2026)


BSP:M2AS34 Masimo Corp BSP:M2AS34
55 GF Score
Price R$39.00
GF Value R$36.87
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Masimo Interest Expense?

Masimo BSP:M2AS34 +27.16% 55 Interest Expense is R$-165 Mil as of Mar. 2026. GuruFocus rates BSP:M2AS34 with a GF Score™ of 55/100 and a GF Value™ of R$36.87 (Fairly Valued). The stock has 9 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Masimo's interest expense for the three months ended in Mar. 2026 was R$ -32 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was R$-165 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Masimo's Operating Income for the three months ended in Mar. 2026 was R$ 405 Mil. Masimo's Interest Expense for the three months ended in Mar. 2026 was R$ -32 Mil. Masimo's Interest Coverage for the quarter that ended in Mar. 2026 was 12.69. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Masimo  (BSP:M2AS34) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Masimo's Interest Expense for the three months ended in Mar. 2026 was R$-32 Mil. Its Operating Income for the three months ended in Mar. 2026 was R$405 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was R$2,465 Mil.

Masimo's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*404.771/-31.901
=12.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Masimo Interest Expense Historical Data

* Premium members only.

The historical data trend for Masimo's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Masimo Interest Expense Chart

Masimo Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.70 -134.81 -230.78 -251.36 -181.13

Masimo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.67 -45.48 -47.19 -40.92 -31.90
BSP:M2AS34
55GF Score
Masimo Corp BSP:M2AS34
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Masimo Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-165 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of R$-165 Mil mean?
Masimo (BSP:M2AS34) has a Interest Expense of R$-165 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Masimo and its competitors.
Is Masimo's Interest Expense too high?
Masimo's current Interest Expense is R$-165 Mil. Overall, Masimo has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Masimo's Interest Expense compare to BRKR and PODD?
Masimo's Interest Expense of R$-165 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Masimo and its competitors. Masimo's current Interest Expense is R$-165 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Masimo stock overvalued right now?
Based on GuruFocus' analysis, Masimo (BSP:M2AS34) is currently considered Fairly Valued. The stock's GF Value™ is R$36.87, compared to a current price of R$39.00 — trading 5.8% above its estimated fair value. The current Interest Expense is R$-165 Mil. Masimo's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Masimo (BSP:M2AS34), the current Interest Expense is R$-165 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Masimo (BSP:M2AS34) Overvalued in 2026?

Based on GuruFocus' analysis, Masimo stock appears to be overvalued. The current stock price of R$39.00 is trading 5.8% above its estimated GF Value™ of R$36.87. GuruFocus considers Masimo to be Fairly Valued.

Key valuation signals for BSP:M2AS34:

  • Interest Expense: R$-165 Mil
  • GF Value™: R$36.87 vs. price of R$39.00 (5.8% above fair value)
  • GF Score™: 55/100 with 9 warning signs

No single metric tells the full story. See the BSP:M2AS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Masimo Business Description

Address 52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
55GF Score

Get the complete analysis for BSP:M2AS34

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$39.00
Price
R$36.87
GF Value